These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11729832)
1. The immunological basis of current and novel therapies of multiple sclerosis. Dubois B; Opdenakker G Arch Immunol Ther Exp (Warsz); 1999; 47(1):7-16. PubMed ID: 11729832 [TBL] [Abstract][Full Text] [Related]
2. Current evidence and therapeutic strategies for multiple sclerosis. Wingerchuk DM Semin Neurol; 2008 Feb; 28(1):56-68. PubMed ID: 18256987 [TBL] [Abstract][Full Text] [Related]
3. Opportunistic infections and other risks with newer multiple sclerosis therapies. Berger JR; Houff S Ann Neurol; 2009 Apr; 65(4):367-77. PubMed ID: 19399841 [TBL] [Abstract][Full Text] [Related]
7. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
8. [Therapy of multiple sclerosis]. Miyatake T Rinsho Shinkeigaku; 1984 Dec; 24(12):1232-4. PubMed ID: 6085568 [No Abstract] [Full Text] [Related]
9. Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments. Galimberti D; Bresolin N; Scarpini E Expert Rev Neurother; 2004 May; 4(3):439-53. PubMed ID: 15853541 [TBL] [Abstract][Full Text] [Related]
10. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews. Clerico M; Rivoiro C; Contessa G; Viglietti D; Durelli L Clin Neurol Neurosurg; 2008 Nov; 110(9):878-85. PubMed ID: 18164542 [TBL] [Abstract][Full Text] [Related]